Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

Trial Profile

CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

Recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Sep 2018

At a glance

  • Drugs Azithromycin (Primary) ; Clarithromycin; Ethambutol; Rifampicin
  • Indications Mycobacterium avium complex infections
  • Focus Therapeutic Use
  • Acronyms CLAZI
  • Most Recent Events

    • 17 Sep 2018 Planned End Date changed from 20 Sep 2022 to 1 Feb 2023.
    • 17 Sep 2018 Planned primary completion date changed from 20 Sep 2022 to 1 Feb 2023.
    • 17 Sep 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top